Clinical Trials, Research and Drug Development Information
Look-up Clinical Trials:
South Carolina Research Studies Directory
Learn More:
NORD Course: From Records to Research: Making Sense of Health Data for Rare Diseases
NORD Course: Rare Disease Drug Development: What Patients and Advocates Need to Know
RDDC & GeneClips: Research, Clinical Trials, & Genetic Testing Educational Video Series
FDA's Drug Designations and Approval Process
-
Abstract: a short summary of the study's purpose, methods, results, and conclusions
-
Accelerated Approval: an FDA program that allows a faster approval process for drugs that treat serious conditions and fill an unmet medical need; drug companies are still required to meet the same requirements as the non-accelerated approvals 2
-
Clinical Trial: a research study that is done to discover answer regarding specific health conditions or treatment options 1
-
Control: a group that serves as a comparison to the experimental group that is being investigated 1
-
Data: information that is collected during a study
-
Hypothesis: an idea that can be tested
-
Literature Review: an overview of published findings related to the topic of study; provides a background for the direction of future studies 4
-
Informed Consent: researchers are required to explain the experiment/clinical trial process and expectations clearly to the study participants; a patient understands that they have the ability to withdraw from the study at anytime 1
-
Institutional Review Board (IRB): a group of individuals, often doctors, scientists, community members etc., that review and monitor research that involves humans to ensure it is meeting ethical standards 1
-
Orphan Drug: a medication that is used to treat a rare disease
-
Patient Registry: an organized collection of data to collect information and track the prevalence of a specific disease to measure patient outcomes
-
Placebo: inactive substances such as medicine that is used to compare the experimental treatment to the control group 1
-
Prescription Drug User Fee Act (PDUFA):
-
Principal Investigator: the person responsible for overseeing the clinical trial, typically a physician or researcher 1
-
Randomization: participants are randomly assigned to their group to ensure the test results are unbiased 1
-
Reliability: a measure of if the results can be replicated when the experiment is repeated under similar conditions 3
-
Validity: a measure of if the results measure what the purposed measure was 3
Clinical Trials & Research Glossary
Involvement Opportunities
An opportunity to contribute to a diverse database of health information that has the potential to lead to future patient-tailored treatments
A no-cost genetic screening opportunity that allows individuals to undergo testing to see if they are at a higher risk for specific conditions in the future
